デフォルト表紙
市場調査レポート
商品コード
1498724

自家ワクチン市場:製品タイプ別、用途別、流通別、技術別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測

Autogenous Vaccines Market, By Product Type, By Application, By Distribution, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 270 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
自家ワクチン市場:製品タイプ別、用途別、流通別、技術別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 270 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

自家ワクチン市場規模は2023年に1億3,092万米ドルとなり、2024年から2032年にかけてCAGR 5.95%で拡大

自家ワクチン市場- 市場力学

厳しい規制枠組が市場成長を阻害する可能性

自家ワクチン産業は、その有利な市場ダイナミクスにもかかわらず、知的財産権、規制の枠組み、技術的限界に関する障害に直面しています。自家ワクチンには、米国農務省の獣医学サービス・ガイドライン(Veterinary Service Memorandum Guidelines for Autogenous Biologics)が適用されます。これらは特別に調製された不活化ワクチンであり、獣医師またはその他の認定された専門家によってのみ投与されます。英国では、販売される動物用医薬品の有効性、安全性、品質を保証する責任当局は獣医医薬品局(Veterinary Medicines Directorate)です。免疫学チームは、免疫学的製剤を製造する施設を検査し、免疫学的製剤の販売承認申請を評価します。製造手順は、自家ワクチンの品質と市場での入手可能性に影響を与える最も重要な要因です。製造手順は規制要件によって最適化されています。

自家ワクチン市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間(2024-2032年)に約5.95%のCAGRで毎年成長すると推定されます。

製品タイプ別では、Bacterial Autogenous Vaccinesが2023年に最大の市場シェアを示すと予測されています。

用途別では、家畜用ワクチンが2023年の主要タイプでした。

エンドユーザー別では、動物病院が2023年の主要タイプでした。

流通セグメント別では、直販が2023年の主要タイプでした。

地域別では、欧州が2023年に収益でリードしました。

自家ワクチン市場-セグメンテーション分析:

自家ワクチンの世界市場は、製品タイプ、用途、流通、技術、エンドユーザー、地域に基づいてセグメント化されます。

市場は用途によって3つのカテゴリーに分けられる:家畜用ワクチン、コンパニオンアニマル用ワクチン、水産養殖用ワクチンです。疾病の脅威を効果的に管理するために、家畜や家禽の個体数が多い大規模農家では、専門的なワクチン接種プログラムを実施する必要があります。バイオセキュリティプロトコルを改善し、持続可能な農法を保証しようとしている大規模農場は、特にカスタマイズされた予防接種戦略を実施する可能性が高いです。

市場は製品タイプによって3つのカテゴリーに分けられる:細菌性自家ワクチン、ウイルス性自家ワクチン、その他です。2023年の養殖魚用自家ワクチン市場は、市場の80%以上を占める細菌分野が牽引しました。アエロモナス、レンサ球菌、ビブリオなどの細菌が病気の原因となることが多いため、これらの問題に対処するために特別に設計されたワクチンの需要が高まっています。特定の養殖場に存在する微生物と闘うために特別に設計されているため、自家ワクチンはユニークです。そのため、病気を食い止めるのに優れています。魚の養殖業者は、製造から使用までが迅速なこのワクチンを愛用するようになった。

自家ワクチン市場-地理的洞察

動物用生物製剤および医薬品産業における調査努力の高まりと、動物ヘルスケアに関連するコストの上昇により、現在、欧州が自家ワクチンの世界市場をリードしています。また、動物用ワクチンの利用が増加し、動物の健康に対する意識が高まった結果、市場が拡大しています。さらに、アジア太平洋地域は最も収益性の高い地域のひとつであり、国際企業にチャンスをもたらしています。これらの地域では、感染症のリスクの高まりや病気の動物の個体数の多さから、自家ワクチンのニーズが高まる可能性があります。

自家ワクチン市場-競合情勢:

自家ワクチン市場の主要企業には、IDT Biologika GmbH、MARINNOVAC、Ceva Biovac、HIPRA、AniCon Labor GmbH、Kennebec River Biosciencesなどがあります。業界内での地位を向上させるため、主要な競合企業は提携、製品発表、M&A、事業拡大などの戦術に注力しています。より幅広い顧客層にサービスを提供するため、Newport Laboratories社などの企業は、例えば、提供する製品を多様化し、新しい層に手を伸ばしています。Ceva Sante Animale社、Phibro Animal Health社、Zoetis社などの大手企業は、その広範な研究開発能力と広範な販売網により、傑出しています。また、特に家畜の数が多く、特定の疾病課題を抱える地域では、地元や地域のメーカーも重要な役割を果たしています。これらのメーカーは、地域の疾病の流行状況を深く理解し、それに応じてソリューションをカスタマイズすることが多いです。

目次

第1章 自家ワクチン市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 自家ワクチンの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 自家ワクチン産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 自家ワクチン市場: COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 自家ワクチン市場情勢

  • 自家ワクチン市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 自家ワクチン市場:製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 細菌性自家ワクチン
    • ウイルス性自家ワクチン
    • その他

第8章 自家ワクチン市場:用途別

  • 概要
    • 用途別セグメントシェア分析
    • 家畜ワクチン
    • ペット用ワクチン
    • 水産養殖ワクチン

第9章 自家ワクチン市場:流通別

  • 概要
    • 流通別セグメントシェア分析
    • 直接販売
    • 代理店販売
    • オンライン販売

第10章 自家ワクチン市場:技術別

  • 概要
    • 技術別セグメントシェア分析
    • 不活化ワクチン
    • 生弱毒化ワクチン
    • サブユニットワクチン
    • トキソイドワクチン

第11章 自家ワクチン市場:エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 獣医クリニック
    • 動物病院
    • 動物農場
    • 水産養殖場

第12章 自家ワクチン市場:地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析:自家ワクチン業界

  • 競合ダッシュボード
  • 企業プロファイル
    • IDT Biologika GmbH
    • MARINNOVAC
    • Ceva Biovac
    • Zoetis(PHARMAQAS)
    • Vaxxinova
    • Barramundi Asia Pte Ltd.(UVAXX Asia)
    • HIPRA
    • AniCon Labor GmbH
    • sanphar(ipeve)
    • Kennebec River Biosciences
    • Others

第14章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Autogenous Vaccines Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Autogenous Vaccines Market, by Product Type 2019-2032 (USD Million)
  • TABLE Autogenous Vaccines Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Autogenous Vaccines Market, by Application 2019-2032 (USD Million)
  • TABLE Autogenous Vaccines Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Autogenous Vaccines Market, by Distribution 2019-2032 (USD Million)
  • TABLE Autogenous Vaccines Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Autogenous Vaccines Market, by Technology 2019-2032 (USD Million)
  • TABLE Autogenous Vaccines Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Autogenous Vaccines Market, by End User 2019-2032 (USD Million)
  • TABLE Autogenous Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Autogenous Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Autogenous Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Autogenous Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Autogenous Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Autogenous Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE North America Autogenous Vaccines Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Autogenous Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Autogenous Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Autogenous Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Autogenous Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Autogenous Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe Autogenous Vaccines Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Autogenous Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Autogenous Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Autogenous Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Autogenous Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Autogenous Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific Autogenous Vaccines Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Autogenous Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Autogenous Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Autogenous Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Autogenous Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Autogenous Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America Autogenous Vaccines Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Autogenous Vaccines Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Autogenous Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Autogenous Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Autogenous Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Autogenous Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Autogenous Vaccines Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Autogenous Vaccines Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2893

REPORT HIGHLIGHT

Autogenous Vaccines Market size was valued at USD 130.92 Million in 2023, expanding at a CAGR of 5.95% from 2024 to 2032.

The rise in infectious diseases among livestock and companion animals drives the demand for autogenous vaccines. These vaccines are crucial for managing outbreaks caused by unique or region-specific pathogens. The ability to customize vaccines to target specific strains in a particular herd or flock increases their effectiveness, making them an attractive option for veterinarians and farmers. The increasing trend of pet ownership and the willingness of pet owners to invest in preventive healthcare for their animals create opportunities for the development and sale of autogenous vaccines for companion animals.

Autogenous Vaccines Market- Market Dynamics

Stringent Regulatory Frameworks Potentially Impede the Market Growth

The autogenous vaccine industry is confronted with obstacles regarding intellectual property rights, regulatory frameworks, and technological limitations, even with its advantageous market dynamics. Regulations and the USDA's Veterinary Service Memorandum Guidelines for Autogenous Biologics apply to autogenous vaccines. These are specially prepared inactivated vaccinations that can only be administered by veterinarians or other authorized professionals. In the United Kingdom, the responsible authority for guaranteeing the effectiveness, safety, and quality of veterinary pharmaceuticals sold is the Veterinary Medicines Directorate. The Immunological team is in charge of inspecting the production facilities that generate immunological products and evaluating immunological applications for marketing authorizations. Manufacturing procedures are the most important factor affecting the quality of autogenous vaccines and their availability on the market. They are optimized by regulatory requirements.

Autogenous Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.95% over the forecast period (2024-2032)

Based on product type segmentation, Bacterial Autogenous Vaccines was predicted to show maximum market share in the year 2023

Based on application segmentation, Livestock Vaccines was the leading type in 2023

Based on end-user segmentation, Veterinary Hospitals was the leading type in 2023

Based on distribution segmentation, Direct Sales was the leading type in 2023

On the basis of region, Europe was the leading revenue generator in 2023

Autogenous Vaccines Market- Segmentation Analysis:

The Global Autogenous Vaccines Market is segmented on the basis of Product Type, Application, Distribution, Technology, End User, and Region.

The market is divided into three categories based on application: Livestock Vaccines, Companion Animal Vaccines, and Aquaculture Vaccines. To effectively manage disease threats, large-scale farming operations with significant populations of cattle or poultry need to implement specialized vaccination programs. Large farms looking to improve biosecurity protocols and guarantee sustainable farming practices are especially likely to implement customized immunization strategies.

The market is divided into three categories based on product type: Bacterial Autogenous Vaccines, Viral Autogenous Vaccine, and Others. With more than 80% of the market, the bacterium segment of the autogenous vaccine market for fish farming led the way in 2023. Since bacteria like Aeromonas, Streptococcus, and Vibrio are frequently the cause of illness, there is a growing demand for vaccines specifically designed to combat these issues. Because they are specifically designed to combat the microorganisms present in a particular fish farm, autogenous vaccines are unique. They are therefore excellent at halting illnesses. Fish growers have come to love these vaccines because of how quickly they can be manufactured and used.

Autogenous Vaccines Market- Geographical Insights

Due to rising research efforts in the veterinary biologics and medicine industries and rising costs associated with providing animal healthcare, Europe is currently leading the world market for autogenous vaccines. Additionally, the market has grown as a result of the rising use of animal vaccines and rising awareness of animal health. Furthermore, Asia Pacific is among the most lucrative regions and is creating opportunities for international firms. The need for autogenous vaccines may rise in these areas due to the rising risk of infectious diseases and the high population of sick animals.

Autogenous Vaccines Market- Competitive Landscape:

Key Players in the Autogenous Vaccines Market include IDT Biologika GmbH, MARINNOVAC, Ceva Biovac, HIPRA, AniCon Labor GmbH, Kennebec River Biosciences etc. To improve their position in the industry, major competitors are concentrating on tactics including collaborations, product launches, mergers and acquisitions, and expansions. To serve a wider client base, businesses such as Newport Laboratories and others are, for instance, diversifying their product offerings and reaching out to new demographics. Major players like Ceva Sante Animale, Phibro Animal Health, and Zoetis are prominent due to their extensive research and development capabilities and broad distribution networks. Local and regional manufacturers also play a crucial role, particularly in regions with high livestock populations and specific disease challenges. These players often deeply understand local disease prevalence and tailor their solutions accordingly.

Recent Developments:

In February 2021, Philippe Mauguin, CEO of INRAE, and Dr. Marc Prikazsky, Chairman & CEO of Ceva Sante Animale, signed a first framework agreement to consolidate their collaboration in animal health.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AUTOGENOUS VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

IDT Biologika GmbH

MARINNOVAC

Ceva Biovac

Zoetis (PHARMAQAS)

Vaxxinova

Barramundi Asia Pte Ltd. (UVAXX Asia)

HIPRA

AniCon Labor GmbH

sanphar (ipeve)

Kennebec River Biosciences

Others

GLOBAL AUTOGENOUS VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Bacterial Autogenous Vaccines
  • Viral Autogenous Vaccine
  • Others

GLOBAL AUTOGENOUS VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Livestock Vaccines
  • Companion Animal Vaccines
  • Aquaculture Vaccines

GLOBAL AUTOGENOUS VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Direct Sales
  • Distributor Sale
  • Online Sale

GLOBAL AUTOGENOUS VACCINES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines

GLOBAL AUTOGENOUS VACCINES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Veterinary Clinic
  • Veterinary Hospitals
  • Animal Farms
  • Aquaculture Farms

GLOBAL AUTOGENOUS VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Autogenous Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Autogenous Vaccines Market Snippet by Product Type
    • 2.1.2. Autogenous Vaccines Market Snippet by Application
    • 2.1.3. Autogenous Vaccines Market Snippet by Distribution
    • 2.1.4. Autogenous Vaccines Market Snippet by Technology
    • 2.1.5. Autogenous Vaccines Market Snippet by End User
    • 2.1.6. Autogenous Vaccines Market Snippet by Country
    • 2.1.7. Autogenous Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. Autogenous Vaccines Key Market Trends

  • 3.1. Autogenous Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Autogenous Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Autogenous Vaccines Market Opportunities
  • 3.4. Autogenous Vaccines Market Future Trends

4. Autogenous Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Autogenous Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Autogenous Vaccines Market Landscape

  • 6.1. Autogenous Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Autogenous Vaccines Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Bacterial Autogenous Vaccines
    • 7.1.3. Viral Autogenous Vaccine
    • 7.1.4. Others

8. Autogenous Vaccines Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Livestock Vaccines
    • 8.1.3. Companion Animal Vaccines
    • 8.1.4. Aquaculture Vaccines

9. Autogenous Vaccines Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Direct Sales
    • 9.1.3. Distributor Sale
    • 9.1.4. Online Sale

10. Autogenous Vaccines Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Inactivated Vaccines
    • 10.1.3. Live Attenuated Vaccines
    • 10.1.4. Subunit Vaccines
    • 10.1.5. Toxoid Vaccines

11. Autogenous Vaccines Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2. Veterinary Clinic
    • 11.1.3. Veterinary Hospitals
    • 11.1.4. Animal Farms
    • 11.1.5. Aquaculture Farms

12. Autogenous Vaccines Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Autogenous Vaccines Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Autogenous Vaccines Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Autogenous Vaccines Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Autogenous Vaccines Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Autogenous Vaccines Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Autogenous Vaccines Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. IDT Biologika GmbH
    • 13.2.2. MARINNOVAC
    • 13.2.3. Ceva Biovac
    • 13.2.4. Zoetis (PHARMAQAS)
    • 13.2.5. Vaxxinova
    • 13.2.6. Barramundi Asia Pte Ltd. (UVAXX Asia)
    • 13.2.7. HIPRA
    • 13.2.8. AniCon Labor GmbH
    • 13.2.9. sanphar (ipeve)
    • 13.2.10. Kennebec River Biosciences
    • 13.2.11. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us